{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T10:24:07Z","timestamp":1794306247992,"version":"4.9.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"am","delay-in-days":348,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000090","name":"Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30-CA016520"],"award-info":[{"award-number":["P30-CA016520"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000892","name":"Prostate Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000892","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.euo.2023.10.016","type":"journal-article","created":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T03:31:01Z","timestamp":1699068661000},"page":"794-803","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Validation of Biomechanical Computed Tomography for Fracture Risk Classification in Metastatic Hormone-sensitive Prostate Cancer"],"prefix":"10.1016","volume":"7","author":[{"given":"John K.","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caleb M.","family":"Hearn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Getzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony M.","family":"Keaveny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravishankar","family":"Jayadevappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle W.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ning","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara N.","family":"Maxwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Narayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi B.","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel U.","family":"Takvorian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel D.","family":"Bikle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet M.","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amna N.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chamith S.","family":"Rajapakse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia K.","family":"Morgans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2692-6306","authenticated-orcid":false,"given":"Ravi B.","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2023.10.016_b0005","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMoa041943","article-title":"Risk of fracture after androgen deprivation for prostate cancer","volume":"352","author":"Shahinian","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euo.2023.10.016_b0010","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.eururo.2014.07.010","article-title":"Adverse effects of androgen deprivation therapy and strategies to mitigate them","volume":"67","author":"Nguyen","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2023.10.016_b0015","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/j.1464-410X.2009.08483.x","article-title":"Long-term changes in bone mineral density and predicted fracture risk in patients receiving androgen-deprivation therapy for prostate cancer, with stratification of treatment based on presenting values","volume":"104","author":"Wadhwa","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2023.10.016_b0020","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1200\/JCO.2010.34.4994","article-title":"Emerging therapies to prevent skeletal morbidity in men with prostate cancer","volume":"29","author":"Saylor","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2023.10.016_b0025","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1200\/JCO.2013.51.6500","article-title":"Randomized controlled trial of early zoledronic acid in men with castration-sensitive prostate cancer and bone metastases: results of CALGB 90202 (Alliance)","volume":"32","author":"Smith","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2023.10.016_b0030","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.mayocp.2018.06.024","article-title":"Limited osteoporosis screening effectiveness due to low treatment rates in a national sample of older men","volume":"93","author":"Col\u00f3n-Emeric","year":"2018","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.euo.2023.10.016_b0035","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/cncr.27830","article-title":"Bone density testing among prostate cancer survivors treated with androgen-deprivation therapy","volume":"119","author":"Morgans","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.euo.2023.10.016_b0040","first-page":"225","article-title":"American Cancer Society prostate cancer survivorship care guidelines","volume":"64","author":"Skolarus","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.euo.2023.10.016_b0045","doi-asserted-by":"crossref","first-page":"e225432","DOI":"10.1001\/jamanetworkopen.2022.5432","article-title":"Association of bone mineral density testing with risk of major osteoporotic fractures among older men receiving androgen deprivation therapy to treat localized or regional prostate cancer","volume":"5","author":"Suarez-Almazor","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.euo.2023.10.016_b0050","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/jbmr.1771","article-title":"Vertebral fractures and trabecular microstructure in men with prostate cancer on androgen deprivation therapy","volume":"28","author":"Greenspan","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.euo.2023.10.016_b0055","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jocd.2011.05.003","article-title":"Vertebral fractures and the misclassification of osteoporosis in men with prostate cancer","volume":"14","author":"Sullivan","year":"2011","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.euo.2023.10.016_b0060","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/924595","article-title":"Predictors of fracture risk and bone mineral density in men with prostate cancer on androgen deprivation therapy","volume":"2011","author":"Neubecker","year":"2011","journal-title":"J Osteoporos"},{"key":"10.1016\/j.euo.2023.10.016_b0065","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s00198-020-05384-2","article-title":"Biomechanical computed tomography analysis (BCT) for clinical assessment of osteoporosis","volume":"31","author":"Keaveny","year":"2020","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.euo.2023.10.016_b0070","unstructured":"U.S. Food and Drug Administration. Device ID K113725 premarket notification (Virtuost). https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfPMN\/pmn.cfm?ID=K113725."},{"key":"10.1016\/j.euo.2023.10.016_b0075","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1359\/jbmr.081201","article-title":"Finite element analysis of the proximal femur and hip fracture risk in older men","volume":"24","author":"Orwoll","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.euo.2023.10.016_b0080","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/jbmr.1539","article-title":"Prediction of new clinical vertebral fractures in elderly men using finite element analysis of CT scans","volume":"27","author":"Wang","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.euo.2023.10.016_b0085","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/jbmr.2069","article-title":"Assessment of incident spine and hip fractures in women and men using finite element analysis of CT scans: incident fracture assessment using FEA of CT scans","volume":"29","author":"Kopperdahl","year":"2014","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.euo.2023.10.016_b0090","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.bone.2017.04.008","article-title":"Vertebral and femoral bone mineral density and bone strength in prostate cancer patients assessed in phantomless PET\/CT examinations","volume":"101","author":"Schwaiger","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.euo.2023.10.016_b0095","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/jamainternmed.2016.9539","article-title":"Effect of testosterone treatment on volumetric bone density and strength in older men with low testosterone a controlled clinical trial","volume":"177","author":"Snyder","year":"2017","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.euo.2023.10.016_b0100","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/jbmr.3423","article-title":"Osteoporosis and hip fracture risk from routine computed tomography scans: the Fracture, Osteoporosis, and CT Utilization Study (FOCUS)","volume":"33","author":"Adams","year":"2018","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.euo.2023.10.016_b0105","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00198-022-06624-3","article-title":"Prevalence of osteoporosis in older male veterans receiving hip-containing computed tomography scans: opportunistic use of biomechanical computed tomography analysis (BCT)","volume":"34","author":"Teng","year":"2023","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.euo.2023.10.016_b0110","unstructured":"The International Society for Clinical Densitometry. Official positions. 2019."},{"key":"10.1016\/j.euo.2023.10.016_b0115","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jocd.2015.06.011","article-title":"Clinical use of quantitative computed tomography\u2013based finite element analysis of the hip and spine in the management of osteoporosis in adults: the 2015 ISCD official positions\u2014part II","volume":"18","author":"Zysset","year":"2015","journal-title":"J Clin Densitom"},{"issue":"6_suppl","key":"10.1016\/j.euo.2023.10.016_b0120","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1200\/JCO.2022.40.6_suppl.019","article-title":"Bone mineral density in men with de novo metastatic castration-sensitive prostate cancer treated with or without abiraterone plus prednisone in the PEACE-1 phase 3 trial","volume":"40","author":"Roubaud","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2023.10.016_b0125","first-page":"1288","article-title":"NCCN Guidelines\u00ae insights: prostate cancer, version 1.2023","volume":"20","author":"Schaeffer","year":"2022","journal-title":"J Natl Compr Canc Netw"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931123002304?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931123002304?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T09:33:45Z","timestamp":1794303225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931123002304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S2588931123002304"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2023.10.016","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation of Biomechanical Computed Tomography for Fracture Risk Classification in Metastatic Hormone-sensitive Prostate Cancer","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2023.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}